evidence table

Ergothioneine Skin Hydration Randomized Trial Evidence Table

Name: Ergothioneine Skin Hydration Randomized Trial Evidence Table
Creator: Migaku
License: https://creativecommons.org/licenses/by/4.0/

Structured evidence table for Ergothioneine Skin Hydration Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topic	claim	evidence level	citation	source
Ergothioneine Skin Hydration Randomized Trial	Nevertheless, the procedure carries a potential risk of post‐inflammatory hyperpigmentation (PIH) [], especially among individuals with Fitzpatrick skin type IV, which is prevalent in the Chinese population [].	2	He Yixuan (2026)	Efficacy of 1064‐Nm Picosecond Nd: YAG Laser in Treating Facial Photoaging and Improving Skin Barrier Enhanced by a Multi‐Beneficial Composition Formulation: A Blinded Randomized Clinical Trial Study
Ergothioneine Skin Hydration Randomized Trial	1 At the end of the study, the efficacy rates for all symptoms were found to be higher on the test sides than on the control sides (Figure ).	2	He Yixuan (2026)	Efficacy of 1064‐Nm Picosecond Nd: YAG Laser in Treating Facial Photoaging and Improving Skin Barrier Enhanced by a Multi‐Beneficial Composition Formulation: A Blinded Randomized Clinical Trial Study
Ergothioneine Skin Hydration Randomized Trial	p p p p Because of postoperative edema, SCH values were significantly increased on both sides at T3d compared with baseline (both < 0.001), indicating a transiently compromised skin barrier, and returned to baseline levels by T8d.	2	He Yixuan (2026)	Efficacy of 1064‐Nm Picosecond Nd: YAG Laser in Treating Facial Photoaging and Improving Skin Barrier Enhanced by a Multi‐Beneficial Composition Formulation: A Blinded Randomized Clinical Trial Study
Ergothioneine Skin Hydration Randomized Trial	EI HA MAPK MI NF‐κB NO Nrf2 PIH SCH SE SSRI TEWL TNF‐α 1 2 3 4 5 In recent years, skin photoaging has received increasing attention.	2	He Yixuan (2026)	Efficacy of 1064‐Nm Picosecond Nd: YAG Laser in Treating Facial Photoaging and Improving Skin Barrier Enhanced by a Multi‐Beneficial Composition Formulation: A Blinded Randomized Clinical Trial Study
Ergothioneine Skin Hydration Randomized Trial	In addition, global life expectancy has increased from 60 to 70 years for both males and females over the last 20 years (B).	4	Sun Yidan (2026)	An integrated anti-aging framework targeting NAD + homeostasis, mitochondrial quality control, and redox stability: Roles of NMN/NR, PQQ, and EGT
Ergothioneine Skin Hydration Randomized Trial	Aging is closely associated with a high incidence of multiple chronic diseases, including congestive heart failure, myocardial infarction, dementia, stroke, most cancers, diabetes and metabolic disorders, renal dysfunction, chronic lung disease, osteoporosis, arthritis, and vision loss [].	4	Sun Yidan (2026)	An integrated anti-aging framework targeting NAD + homeostasis, mitochondrial quality control, and redox stability: Roles of NMN/NR, PQQ, and EGT
Ergothioneine Skin Hydration Randomized Trial	Particular attention was given to compounds with substantial experimental evidence demonstrating their ability to modulate mitochondrial metabolism, mitochondrial biogenesis and quality control, or mitochondrial redox stability.	4	Sun Yidan (2026)	An integrated anti-aging framework targeting NAD + homeostasis, mitochondrial quality control, and redox stability: Roles of NMN/NR, PQQ, and EGT
Ergothioneine Skin Hydration Randomized Trial	1 4 5 1 2 A: Global Population Aged 60 and Over and Related Percentage; B: Global Life Expectancy.	4	Sun Yidan (2026)	An integrated anti-aging framework targeting NAD + homeostasis, mitochondrial quality control, and redox stability: Roles of NMN/NR, PQQ, and EGT